1.
ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005.
Am J Respir Crit Care Med 2005;171:912-930.
Hyperlink to the abstract in the PubMed Database.
2.
Silkoff PE, et al.
The Aerocrine exhaled nitric oxide monitoring system NIOX is cleared by the US Food and Drug Administration for monitoring therapy in asthma.
J Allergy Clin Immunol 2004;114:1241-56.
Hyperlink to the abstract in the PubMed Database.
3.
Kharitonov SA, Gonio F, Kelly C, Meah S, Barnes PJ.
Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children.
Eur Respir J. 2003 Mar;21(3):433-8.
Hyperlink to the abstract in the PubMed Database.
4.
FDA Talk Paper, FDA Clears New Breath Test for Monitoring Asthma
May 1, 2003, Document Nr. T03-33
Hyperlink to the FDA Talk Paper.
5.
Kharitonov SA, Walker L, Barnes PJ.
Repeatability of standardised nasal nitric oxide measurements in healthy and asthmatic adults and children.
Respir Med. 2005 Sep;99(9):1105-14.
Hyperlink to the abstract in the PubMed Database.
6.
George SC, Hogman M, Permutt S, Silkoff PE.
Modeling pulmonary nitric oxide exchange. J Appl Physiol 2004 Mar;96:831–9.
Hyperlink to the abstract in the PubMed Database.
7.
Tsoukias NM, George SC.
A two-compartment model of pulmonary nitric oxide exchange dynamics. J Appl
Physiol 1998;85:653–66.
Hyperlink to the abstract in the PubMed Database.
 |
 |
Aerocrine ©
|
